Abbott India Ltd.

27,610

-75 (-0.3%)growUp

ABBOTINDIA Share Price
As on January 28, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap58,635 Cr
P/E Ratio41.48
Dividend Yield0.17 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open27,895
High27,895
NSE SymbolABBOTINDIA
Close27,610
Low27,515
BSE Symbol500488
Previous Years High/Low
1 Year High37,000
3 Year High37,000
5 Year High37,000
1 Year Low25,325
3 Year Low19,900
5 Year Low13,959.8

Technicals


IndicatorsValueSignal
5-DMA27,675Bearish
10-DMA27,706Bearish
20-DMA28,063.5Bearish
50-DMA28,546.1Bearish
100-DMA29,328.25Bearish
200-DMA30,711.12Bearish

Historical Performance


1 Year
7.4%
3 Years
30.2%
5 Years
89.4%
10 Years
443.7%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsNov-2001
Net Sales3,563
Total Expenditure3,059
Other Income205
Operating Profit709
Interest1
Depreciation45
Profit Before Tax663
Consolidated Net Profit497
Adjusted EPS31
Compounded Sales Growth
10 Years:22.9
5 Years:9.4
3 Years:5.5
TTM:1.8
Compounded Profit Growth
10 Years:43.9
5 Years:19
3 Years:12.1
TTM:3.3
Stock Price CAGR
10 Years:18.5
5 Years:14.2
3 Years:9.2
TTM:8.3
Return on Equity
10 Years:120.1
5 Years:325
3 Years:446.8
last year:665.6

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 41.48, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 9.6%, reflecting average market performance.
  • The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹19702 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹64091 million, indicating a large and established business.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 1082668.7
No. of Shares: 39 (Approx)
Performance:8.3%
P/L: ₹82668.7
NIFTY Performance: 9.4%
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

68.6%

40.1

1 Month Performance

NGL Fine-Chem Ltd.

29.3%

1710.5

1 Month Performance

Ind-Swift Laboratories Ltd.

18.8%

108.7

1 Month Performance

Acutaas Chemicals Ltd.

12.7%

1862.4

1 Month Performance

Zim Laboratories Ltd.

9%

74.77

1 Month Performance

Torrent Pharmaceuticals Ltd.

3.7%

3958.7

1 Month Performance

Alkem Laboratories Ltd.

3.4%

5722.5

1 Month Performance

Alivus Life Sciences Ltd.

2.8%

932.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month